Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Ghrelin and Obestatin | Main | Okadaic Acid Makes Vanity Fair »

November 30, 2005

Merck Update

Email This Entry

Posted by Derek

Despite an AP story today that named a Merck/Banyu research site in Japan, It looks like it's the Merck research site in England (Terlings Park, Harlow, Essex) that will close, as some rumors already had it. A comment was left to the post below that seems to confirm things, and I believe that it's authentic.

I'm sorry to see it. They've been doing good work there for a long time - a large part of the Substance P story that I spoke about here was done at Terlings Park, for example. Here's hoping that Merck doesn't have to cut more in the future.

Comments (8) + TrackBacks (0) | Category: Current Events


COMMENTS

1. Stacey S on December 1, 2005 2:23 PM writes...

Hi Derick.
A question about these plant closings.....
Some politicians in Florida are advocating the creation of new biomedical enterprize zones to encourage pharma to move manufacturing here. They're trying to assemble a good list of incentives that could make us more attractive than Puerto Rico, for example.
I'm wondering:
1) My sources say coming FDA approvals of biologicals are going to require lots of capital investment in the near future. True or false?
2) What do you think about putting such plants at the headwaters of the Everglades / in an active hurricane zone. Any concerns?
3) What types of incentives would work? Soverign immunity? TIFs?
4) Is anyone really building these plants in the United States? Why/why not?

Thanks!
Stacey S

Permalink to Comment

2. BritChemist on December 2, 2005 5:16 AM writes...

You know, I'm not overly surprised that some of the Merck places over here in the UK are due to close.

Each year for the last 4-5 years they've been putting out ads for chemists (that I've noticed, anyway), and each year I have either been personally involved, or know people who have been involved, in trying to get a job there. We hear nothing for 4-5 months after application, trying to phone just leads to voicemails, and unanswered mail (both good old fashioned paper and e-mail) then suddenly out of the blue we get a letter saying the positions are on hold pending a budget review or similar.

Still, it's a shame if Terlings Park is going to close, from what I understand it's quite a pleasant site. I suupose one of the problems is that there's a lot of biotech concerns locally (it's close to both Cambridge and London), many of which seem to be doing similar stuff. Oh well, time to try and find somewhere else to concentrate my job efforts then for now.

S

Permalink to Comment

3. Belbo on December 2, 2005 7:34 PM writes...

Terlings may be toast, but at least there's a silver lining for the PR&D folks at Hoddesdon

http://www.herts-essex-news.co.uk/news/mercury/hoddesdon_mercury/2005/12/02/400%20jobs%20are%20safe.lpf

"MSD managing director Vincent Lawton said Hoddesdon would be at the heart of the firm's restructured UK operations.

"The recent investment to establish a new global centre of excellence in chemistry at Hoddesdon, to serve the needs of Merck's organics and synthetic chemistry organisation, will be completed in spring 2006,"

Permalink to Comment

4. Insider on December 3, 2005 6:34 AM writes...

I'm not sure that the process research department in Hoddesdon will be safe in the long term. Much of their workload came from Terlings Park projects and Merck could easily decide to conslidate all process chemistry to the USA. Merck have just invested a great deal of money in a state of the art animal facility at TP, which will be abandoned with the rest of the site.

Permalink to Comment

5. joan Petty on March 29, 2008 10:24 PM writes...

I have a comment for you. Merck is a German owned company and not American. The parent Company is E-Merck located in Germany and owns 70% of the stock and Merck KGaA Inc. owns 30% of the stock and Merck in N.J. is a subsidary of the E-Merck. Merck is Globle and in 90 countries. They merge with any and all Chemical Companies or any prescription drug company they can take over or control. If they come to Florida it will be to build a chemical company on the coast so if a hurrican hits it will contamiate as much of the enviorment as possible. Their Motto is to rule the Wrold. Merck is out to kill as many humans as they can.

Permalink to Comment

6. eugene on March 30, 2008 3:36 PM writes...

"Merck is out to kill as many humans as they can."

You'd think that if the Merck CEO hated humanity that much, he would kill his family and commit hari-kiri before getting anything done. It must be a deep and very disciplined form of hatred if it makes him ignore his own self-loathing just long enough to control the world and end it all in one fell swoop.

I hope someone stops that guy and the VP.

Permalink to Comment

7. Anon on March 30, 2008 4:28 PM writes...

Joan Petty is either a troll or an idiot.

Since the poster can't spell "global", I'm betting on idiot.

Merck hasn't been a German company since, like, 1912 or something. Two completely separate companies. Where do you read this total BS?

Permalink to Comment

8. Joan Petty on September 21, 2009 7:36 PM writes...

Anon, you can look up on the Web and read all the Merck history. You might want to know that anyone can make a typo error and still not be an idiot. I don't see you doing anything constructive or even interesting when you go after someone else. Your comments are full of air. If you are so smart why don't you look up Merck's history on the Web site and read it for yourself.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Gitcher SF5 Groups Right Here
Changing A Broken Science System
One and Done
The Latest Protein-Protein Compounds
Professor Fukuyama's Solvent Peaks
Novartis Gets Out of RNAi
Total Synthesis in Flow
Sweet Reason Lands On Its Face